Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH

Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH

• CAS Number: 131287-39-3
• UNSPSC Description: Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH (Fmoc-Asn(Ac3AcNH-beta-Glc)-OH) can be used in the synthesis of silicon-fluoride acceptor (SiFA) derivatized octreotate derivatives. SiFA-octreotate analogues, as tumor imaging agents, are useful tool for the research of positron emission tomography (PET)[1].
• Target Antigen: Amino Acid Derivatives
• Type: Reference compound
• Related Pathways: Others
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/fmoc-l-asn-beta-d-glcnac-ac-3-oh.html
• Solubility: DMSO : 125 mg/mL (ultrasonic)
• Smiles: CC(N[C@H]([C@H]([C@@H]([C@H](O1)COC(C)=O)OC(C)=O)OC(C)=O)[C@@H]1NC(C[C@@H](C(O)=O)NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)=O)=O
• Molecular Weight: 683.66
• References & Citations: [1]Wängler C, et al. One-step ^¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET). Bioconjug Chem. 2010;21(12):2289-2296.
• Shipping Conditions: Room Temperature
• Clinical Information: No Development Reported